Plasminogen activators and ischemic stroke: conditions for acute delivery.

about

Cocktail treatment, a promising strategy to treat acute cerebral ischemic stroke?

P2860

Q28077232-27E0965D-B153-4B91-8AE4-A1E34EF514C5

P2860

Plasminogen activators and ischemic stroke: conditions for acute delivery.

Item

http://www.wikidata.org/entity/Q36988667

description

2013 nî lūn-bûn

@nan

2013年の論文

@ja

2013年論文

@yue

2013年論文

@zh-hant

2013年論文

@zh-hk

2013年論文

@zh-mo

2013年論文

@zh-tw

2013年论文

@wuu

2013年论文

@zh

2013年论文

@zh-cn

name

Plasminogen activators and ischemic stroke: conditions for acute delivery.

@en

type

Item

label

Plasminogen activators and ischemic stroke: conditions for acute delivery.

@en

prefLabel

Plasminogen activators and ischemic stroke: conditions for acute delivery.

@en

P1476

Plasminogen activators and ischemic stroke: conditions for acute delivery.

@en

P2093

Gregory J del Zoppo

http://www.w3.org/2001/XMLSchema#string

P2860

Thrombolysis for acute ischaemic stroke

Anticoagulants for preventing recurrence following presumed non-cardioembolic ischaemic stroke or transient ischaemic attack

Intravenous ancrod for treatment of acute ischemic stroke: the STAT study: a randomized controlled trial. Stroke Treatment with Ancrod Trial

Tinzaparin in acute ischaemic stroke (TAIST): a randomised aspirin-controlled trial

Indications for early aspirin use in acute ischemic stroke : A combined analysis of 40 000 randomized patients from the chinese acute stroke trial and the international stroke trial. On behalf of the CAST and IST collaborative groups

Risk factors for severe hemorrhagic transformation in ischemic stroke patients treated with recombinant tissue plasminogen activator: a secondary analysis of the European-Australasian Acute Stroke Study (ECASS II)

Antithrombotic therapy in patients with mechanical and biological prosthetic heart valves

Risks and benefits of adding anti-platelet therapy to warfarin among patients with prosthetic heart valves: a meta-analysis

Occult bleeding in three different antithrombotic regimes after myocardial infarction. A WARIS-II subgroup analysis

A comparison of warfarin and aspirin for the prevention of recurrent ischemic stroke

P304

406-425

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1055/S-0033-1338126

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2013-03-28T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

23539414

http://www.w3.org/2001/XMLSchema#string

P932

3703437

http://www.w3.org/2001/XMLSchema#string

Plasminogen activators and ischemic stroke: conditions for acute delivery.

about

P2860

P2860

Plasminogen activators and ischemic stroke: conditions for acute delivery.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P932